Baruch D I, Gormely J A, Ma C, Howard R J, Pasloske B L
Affymax Research Institute, Santa Clara, CA 95051, USA.
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3497-502. doi: 10.1073/pnas.93.8.3497.
Adherence of mature Plasmodium falciparum parasitized erythrocytes (PRBCs) to microvascular endothelium contributes directly to acute malaria pathology. We affinity purified molecules from detergent extracts of surface-radioiodinated PRBCs using several endothelial cell receptors known to support PRBC adherence, including CD36, thrombospondin (TSP), and intercellular adhesion molecule 1 (ICAM-1). All three host receptors affinity purified P. falciparum erythrocyte membrane protein 1 (PfEMP1), a very large malarial protein expressed on the surface of adherent PRBCs. Binding of PfEMP1 to particular host cell receptors correlated with the binding phenotype of the PRBCs from which PfEMP1 was extracted. Preadsorption of PRBC extracts with anti-PfEMP1 antibodies, CD36, or TSP markedly reduced PfEMP1 binding to CD36 or TSP. Mild trypsinization of intact PRBCs of P. falciparum strains shown to express antigenically different PfEMP1 released different (125)I-labeled tryptic fragments of PfEMP1 that bound specifically to CD36 and TSP. In clone C5 and strain MC, these activities resided on different tryptic fragments, but a single tryptic fragment from clone ItG-ICAM bound to both CD36 and TSP. Hence, the CD36- and TSP-binding domains are distinct entities located on a single PfEMP1 molecule. PfEMP1, the malarial variant antigen on infected erythrocytes, is therefore a receptor for CD36, TSP, and ICAM-1. A therapeutic approach to block or reverse adherence of PRBCs to host cell receptors can now be pursued with the identification of PfEMP1 as a malarial receptor for PRBC adherence to host proteins.
成熟的恶性疟原虫寄生红细胞(PRBCs)与微血管内皮的黏附直接导致急性疟疾病理变化。我们使用几种已知支持PRBC黏附的内皮细胞受体,从经表面放射性碘化的PRBC去污剂提取物中亲和纯化分子,这些受体包括CD36、血小板反应蛋白(TSP)和细胞间黏附分子1(ICAM-1)。所有这三种宿主受体都能亲和纯化恶性疟原虫红细胞膜蛋白1(PfEMP1),这是一种在黏附性PRBC表面表达的非常大的疟疾蛋白。PfEMP1与特定宿主细胞受体的结合与从中提取PfEMP1的PRBC的结合表型相关。用抗PfEMP1抗体、CD36或TSP对PRBC提取物进行预吸附,可显著降低PfEMP1与CD36或TSP的结合。对显示表达抗原性不同的PfEMP1的恶性疟原虫菌株的完整PRBC进行轻度胰蛋白酶处理,可释放出不同的(125)I标记的PfEMP1胰蛋白酶片段,这些片段能特异性结合CD36和TSP。在克隆C5和菌株MC中,这些活性存在于不同的胰蛋白酶片段上,但来自克隆ItG-ICAM的单个胰蛋白酶片段能同时结合CD36和TSP。因此,CD36和TSP结合域是位于单个PfEMP1分子上的不同实体。因此,感染红细胞上的疟疾变异抗原PfEMP1是CD36、TSP和ICAM-1的受体。现在,随着PfEMP1被鉴定为PRBC黏附宿主蛋白的疟疾受体,可以寻求一种阻断或逆转PRBC与宿主细胞受体黏附的治疗方法。